These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 13397433)
21. The oral therapy of diabetes mellitus remedia Hoechst rastinon; information arranged and published. HOECHST F Cyprus Med J; 1956; 8(7-8):352-61. PubMed ID: 13384043 [No Abstract] [Full Text] [Related]
22. [Clinical report on 450 diabetics treated with the oral antidiabetic, rastinon Hoechst (D 860)]. WEHLING H Munch Med Wochenschr; 1956 Dec; 98(49):1699-704. PubMed ID: 13387613 [No Abstract] [Full Text] [Related]
23. The mechanism of action of the sulfonylureas in diabetes mellitus. LEVINE R; SOBEL GW Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633 [No Abstract] [Full Text] [Related]
25. Sulfonylureas and diabetes mellitus. I. Clinical evaluation. COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475 [No Abstract] [Full Text] [Related]
26. Current status of aryl sulfonylureas in treatment of diabetes mellitus. DAVIDSON JW; UNGER RH J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329 [No Abstract] [Full Text] [Related]
27. New orally effective adjuvants in the management of diabetes mellitus. O'DONOVAN CJ J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693 [No Abstract] [Full Text] [Related]
28. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference. KRAHL ME; LUKENS FD; RICKETTS HT Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436 [No Abstract] [Full Text] [Related]
29. Metabolic effects of arylsulfonylurea compounds in normal subjects and in diabetic patients. CONN JW; FAJANS SS; HENNES AR; WAJCHENBERG BL Diabetes; 1957; 6(1):41-3; discussion, 43-5. PubMed ID: 13397421 [No Abstract] [Full Text] [Related]
30. Oral treatment of diabetes mellitus with the sulfonamide BZ-55. HERNBERG CA Acta Endocrinol (Copenh); 1956 Nov; 23(3):281-8. PubMed ID: 13381391 [No Abstract] [Full Text] [Related]
31. Clinical use of oral sulfonylurea compounds in diabetes mellitus. COLWELL AR; COLWELL JA Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644 [No Abstract] [Full Text] [Related]
32. The hypoglucemic sulfonylurea drugs; an interim evaluation. STETTEN D Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912 [No Abstract] [Full Text] [Related]
34. BZ 55 and D 860 in the treatment of diabetes mellitus. SCHNEIDER T; POLITZER WM S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061 [No Abstract] [Full Text] [Related]
35. The value of BZ 55 in control of diabetes. MURRAY I; WANG I Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512 [No Abstract] [Full Text] [Related]
36. Studies on the mechanism of action of orinase (tolbutamide). VAUGHAN M Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412 [No Abstract] [Full Text] [Related]
37. Clinical studies on the hypoglycaemic action of the sulphonylureas. BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585 [No Abstract] [Full Text] [Related]
38. Studies of the mechanism of action of sulfonylurea derivatives. GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423 [No Abstract] [Full Text] [Related]